Kase N - Search Results

1

TMEM176B Regulates AKT/mTOR Signaling and Tumor Growth in Triple-Negative Breast Cancer.

Kang C, Rostoker R, Ben-Shumel S, Rashed R, Duty JA, Demircioglu D, Antoniou IM, Isakov L, Shen-Orr Z, Bravo-Cordero JJ, Kase N, Cuajungco MP, Moran TM, LeRoith D, Gallagher EJ. Kang C, et al. Among authors: kase n. Cells. 2021 Dec 6;10(12):3430. doi: 10.3390/cells10123430. Cells. 2021. PMID: 34943938 Free PMC article.

2

Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling.

Scully T, Kase N, Gallagher EJ, LeRoith D. Scully T, et al. Among authors: kase n. Sci Rep. 2021 Sep 9;11(1):17927. doi: 10.1038/s41598-021-97327-y. Sci Rep. 2021. PMID: 34504181 Free PMC article.

3

Unregulated LDL cholesterol uptake is detrimental to breast cancer cells.

Scully T, Ettela A, Kase N, LeRoith D, Gallagher EJ. Scully T, et al. Among authors: kase n. Endocr Relat Cancer. 2022 Dec 12;30(1):e220234. doi: 10.1530/ERC-22-0234. Print 2023 Jan 1. Endocr Relat Cancer. 2022. PMID: 36256855

4

Metformin and Cancer: Is This the End?

Gallagher EJ, Kase NG, Bickell NA, LeRoith D. Gallagher EJ, et al. Among authors: kase ng. Endocr Pract. 2022 Aug;28(8):832-834. doi: 10.1016/j.eprac.2022.06.005. Epub 2022 Jun 18. Endocr Pract. 2022. PMID: 35724834 No abstract available.

5

Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia.

Gallagher EJ, Zelenko Z, Neel BA, Antoniou IM, Rajan L, Kase N, LeRoith D. Gallagher EJ, et al. Among authors: kase n. Oncogene. 2017 Nov 16;36(46):6462-6471. doi: 10.1038/onc.2017.247. Epub 2017 Jul 31. Oncogene. 2017. PMID: 28759039 Free PMC article.

6

The midlife transition and the risk of cardiovascular disease and cancer Part I: magnitude and mechanisms.

Kase NG, Gretz Friedman E, Brodman M, Kang C, Gallagher EJ, LeRoith D. Kase NG, et al. Am J Obstet Gynecol. 2020 Dec;223(6):820-833. doi: 10.1016/j.ajog.2020.05.051. Epub 2020 Jun 1. Am J Obstet Gynecol. 2020. PMID: 32497614 Review.

7

The midlife transition and the risk of cardiovascular disease and cancer Part II: strategies to maximize quality of life and limit dysfunction and disease.

Kase NG, Gretz Friedman E, Brodman M. Kase NG, et al. Am J Obstet Gynecol. 2020 Dec;223(6):834-847.e2. doi: 10.1016/j.ajog.2020.06.008. Epub 2020 Jun 10. Am J Obstet Gynecol. 2020. PMID: 32533929 Review.

8

Aging, the menopausal transition, and hormone replenishment therapy: retrieval of confidence and compliance.

Saul SR, Kase N. Saul SR, et al. Among authors: kase n. Ann N Y Acad Sci. 2019 Mar;1440(1):5-22. doi: 10.1111/nyas.13952. Epub 2018 Oct 4. Ann N Y Acad Sci. 2019. PMID: 30288749

9

Gynecologic manifestations of Sjögren's syndrome.

Lehrer S, Bogursky E, Yemini M, Kase NG, Birkenfeld A. Lehrer S, et al. Among authors: kase ng. Am J Obstet Gynecol. 1994 Mar;170(3):835-7. doi: 10.1016/s0002-9378(94)70294-2. Am J Obstet Gynecol. 1994. PMID: 8141212

10

Time and the risk of ruptured tubal pregnancy.

Bickell NA, Bodian C, Anderson RM, Kase N. Bickell NA, et al. Among authors: kase n. Obstet Gynecol. 2004 Oct;104(4):789-94. doi: 10.1097/01.AOG.0000139912.65553.58. Obstet Gynecol. 2004. PMID: 15458903

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters